Austar Lifesciences Ltd. (6118) Financial Statements

0 Followers

Austar Lifesciences Ltd. Financial Overview

Austar Lifesciences Ltd.'s market cap is currently HK$415.19M. The company's EPS TTM is HK$0.0669; its P/E ratio is 11.85; Austar Lifesciences Ltd. is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	¥ 1.53B	¥ 1.50B	¥ 1.76B	¥ 2.16B	¥ 2.02B
Gross Profit	¥ 293.27M	¥ 301.22M	¥ 336.05M	¥ 488.80M	¥ 479.01M
Operating Income	¥ 54.15M	¥ 35.18M	¥ -29.99M	¥ 116.37M	¥ 311.92M
EBITDA	¥ 73.05M	¥ 70.71M	¥ 25.15M	¥ 159.79M	¥ 130.62M
Net Income	¥ 33.80M	¥ 16.08M	¥ -113.47M	¥ 87.46M	¥ 277.30M
Balance Sheet
Cash & Short-Term Investments	¥ 276.59M	¥ 167.81M	¥ 173.76M	¥ 148.13M	¥ 219.74M
Total Assets	¥ 2.13B	¥ 2.08B	¥ 2.16B	¥ 2.39B	¥ 2.04B
Total Debt	¥ 343.82M	¥ 401.95M	¥ 496.20M	¥ 336.55M	¥ 155.22M
Net Debt	¥ 67.23M	¥ 235.15M	¥ 332.43M	¥ 202.92M	¥ -43.22M
Total Liabilities	¥ 1.30B	¥ 1.29B	¥ 1.38B	¥ 1.51B	¥ 1.26B
Stockholders' Equity	¥ 822.90M	¥ 791.41M	¥ 773.01M	¥ 896.94M	¥ 786.58M
Cash Flow
Free Cash Flow	¥ 99.74M	¥ 78.31M	¥ -133.59M	¥ -155.25M	¥ -204.02M
Operating Cash Flow	¥ 128.24M	¥ 98.81M	¥ -62.65M	¥ -37.93M	¥ -103.45M
Investing Cash Flow	¥ -15.58M	¥ 4.43M	¥ -54.47M	¥ -153.14M	¥ 65.02M
Financing Cash Flow	¥ -42.76M	¥ -101.32M	¥ 147.12M	¥ 125.30M	¥ 59.35M

Currency in CNY

Austar Lifesciences Ltd. Earnings and Revenue History

Income Statement >

Austar Lifesciences Ltd. Debt to Assets

Balance Sheet >

Austar Lifesciences Ltd. Cash Flow

Cash Flow >

Austar Lifesciences Ltd. Forecast EPS vs Actual EPS

Earnings >